Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析

◆英語タイトル:Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1049
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Clariant International Ltd (CLN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Clariant International Ltd (Clariant) is a specialty chemicals company. It develops, manufactures, distributes and sells a broad range of specialty chemicals which are used in customers’ manufacturing and treatment processes. Its product portfolio includes additives, pigments, automotive fluids, agricultural residues, petrochemical catalysts, performance materials, surfactants, mining chemicals, intermediates and emulsions. The company’s products find application in industrial, home care, paints and coatings, crop protection, automotive, plastic, transportation, refining and pharmaceuticals markets. It operates through a network of manufacturing facilities, research and development, and technical centers across the world. The company sells its products in Europe, Asia, Middle East, Africa and the Americas. Clariant is headquartered in Muttenz, Switzerland.

Clariant International Ltd Key Recent Developments

Nov 13,2019: Clariant Catalysts opens third engineering services office in APAC
Aug 15,2019: Successful Startup of World’s Largest Dehydrogenation Plant Using Clariant’s Catofin Catalyst Technology
Jul 25,2019: Clariant grows sales and operating cash flow in first half year 2019
Jul 24,2019: Clariant’s Board of Directors accepted resignation of CEO Ernesto Occhiello
Feb 12,2019: Clariant’s Styromax Ul3 Catalyst delivers excellent results at Shandong Yuhuang styrene plant in China

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Clariant International Ltd – Key Facts
Clariant International Ltd – Key Employees
Clariant International Ltd – Key Employee Biographies
Clariant International Ltd – Major Products and Services
Clariant International Ltd – History
Clariant International Ltd – Company Statement
Clariant International Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Clariant International Ltd – Business Description
Business Segment: Care Chemicals
Overview
Performance
Key Stats
Business Segment: Catalysis
Overview
Key Stats
Business Segment: Catalysis?
Performance
Business Segment: Natural Resources
Overview
Performance
Key Stats
Business Segment: Plastics & Coatings
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: MEA
Performance
Geographical Segment: North America
Performance
R&D Overview
Clariant International Ltd – Corporate Strategy
Clariant International Ltd – SWOT Analysis
SWOT Analysis – Overview
Clariant International Ltd – Strengths
Clariant International Ltd – Weaknesses
Clariant International Ltd – Opportunities
Clariant International Ltd – Threats
Clariant International Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s, Oil & Gas, Power Financial Deals and Alliances
Clariant International Ltd, Petrochemicals, Deals By Year, 2014 to YTD 2020
Clariant International Ltd, Petrochemicals, Deals By Type, 2014 to YTD 2020
Clariant International Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2019: Clariant Catalysts opens third engineering services office in APAC
Aug 15, 2019: Successful Startup of World’s Largest Dehydrogenation Plant Using Clariant’s Catofin Catalyst Technology
Jul 25, 2019: Clariant grows sales and operating cash flow in first half year 2019
Jul 24, 2019: Clariant’s Board of Directors accepted resignation of CEO Ernesto Occhiello
Feb 12, 2019: Clariant’s Styromax Ul3 Catalyst delivers excellent results at Shandong Yuhuang styrene plant in China
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Clariant International Ltd, Key Facts
Clariant International Ltd, Key Employees
Clariant International Ltd, Key Employee Biographies
Clariant International Ltd, Major Products and Services
Clariant International Ltd, History
Clariant International Ltd, Subsidiaries
Clariant International Ltd, Joint Venture
Clariant International Ltd, Key Competitors
Clariant International Ltd, Ratios based on current share price
Clariant International Ltd, Annual Ratios
Clariant International Ltd, Annual Ratios (Cont...1)
Clariant International Ltd, Annual Ratios (Cont...2)
Clariant International Ltd, Interim Ratios
Clariant International Ltd, Petrochemicals, Deals By Year, 2014 to YTD 2020
Clariant International Ltd, Petrochemicals, Deals By Type, 2014 to YTD 2020
Clariant International Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Clariant International Ltd, Performance Chart (2014 - 2018)
Clariant International Ltd, Ratio Charts
Clariant International Ltd, Petrochemicals, Deals By Year, 2014 to YTD 2020
Clariant International Ltd, Petrochemicals, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Adaro Energy Tbk:企業の戦略・SWOT・財務情報
    PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Adaro Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • Skinvisible Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc, is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company provides products su …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Eurasian Natural Resources Corporation Ltd:企業のM&A・事業提携・投資動向
    Eurasian Natural Resources Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurasian Natural Resources Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • FIT Biotech Oy (FITBIO):企業の財務・戦略的SWOT分析
    Summary FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy is a biotechnology company that develops and commercializes gene-based treatments for cancer and a range of infectious diseases. Its patented gene transfer technology is used for the development of drug candidates which inclu …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Omega Diagnostics Group Plc (ODX):企業の製品パイプライン分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests fo …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Orbit International Corp.:戦略・SWOT・企業財務分析
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dakota Valley Electric Cooperative:企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • Altona Energy Plc:企業の戦略・SWOT・財務分析
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • NxStage Medical Inc:企業の戦略的SWOT分析
    NxStage Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lea County Electric Cooperative Inc:企業の発電所・SWOT分析2018
    Lea County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Avista Corporation
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆